[ad_1] TEL AVIV (Reuters) – Israel's RedHill Biopharma said on Monday it had positive safety and efficacy results from a late-stage clinical trial with Crohn's disease called RHB-104. The study puts its …
Read More »Can-Fite BioPharma Receives Australian and Chinese Patents for a New Drug for the Treatment of Erectile Dysfunction
[ad_1] July 17, 2018 Can-Fite BioPharma Ltd., a biotechnology company that develops a portfolio of proprietary small molecule drugs that address liver disease, inflammatory diseases, and badual dysfunction, announced today. The Australian …
Read More »